Many individuals diagnosed with schizoaffective disorder are also diagnosed with other mental disorders, especially substance use disorders and anxiety disorders. Similarly, the incidence of medical conditions is increased above base rate for the general population and leads to decreased life expectancy.
A. Presence of one or both of the following symptoms: 1. Delusions.
2. Hallucinations.
B. There is evidence from the history, physical examination, or laboratory findings of both (1) and (2): 1. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication.
2. The involved substance/medication is capable of producing the symptoms in Crite- rion A.
C. The disturbance is not better explained by a psychotic disorder that is not substance/ medication—induced. Such evidence of an independent psychotic disorder could in- clude the following:
The symptoms preceded the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe intoxication; or there is other evidence of an indepen- dent non-substance/medication-induced psychotic disorder (e.g., a history of recur- rent non-substance/medication-re|ated episodes).
D. The disturbance does not occur exclusively during the course of a delirium.
E. The disturbance causes clinically significant distress or impairment in social, occupa- tional, or other important areas of functioning.
Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and when they are sufficiently severe to warrant clinical attention.
Coding note: The |CD-9-CM and |CD-10—CM codes for the [specific substance/medica- tion]-induced psychotic disorders are indicated in the table below. Note that the |CD-10-
CM code depends on whether or not there is a comorbid substance use disorder present for the same class of substance. If a mild substance use disorder is comorbid with the sub- stance-induced psychotic disorder, the 4th position character is “1 and the clinician should record “mild [substance] use disorder” before the substance—induced psychotic disorder (e.g., “mild cocaine use disorder with cocaine-induced psychotic disorder”). It a moderate or severe substance use disorder is comorbid with the substance-induced psychotic disor- der, the 4th position character is “,"2 and the clinician should record “moderate [substance] use disorder” or “severe [substance] use disorder," depending on the severity of the co- morbid substance use disorder. If there is no comorbid substance use disorder (e.g., after a one-time heavy use of the substance). then the 4th position character is “9“ and the cli- nician should record only the substance-induced psychotic disorder.
With use disorder. Without disorder, moderate use
Alcohol 291.9 F10.159 F10.259 F10.959
Cannabis 292.9 F12.159 F12.259 F12.959
Phencyclidine 292.9 F16.159 F16.259 F16.959
Other hallucinogen 292.9 F16.159 F16.259 F16.959
Inhalant 292.9 F18.159 F18.259 F18.959
Sedative, hypnotic, or 292.9 F13.159 F13.259 F13.959
Amphetamine (or other 292.9 F15.159 F15.259 F15.959